The Role of Botulinum Toxin A in Post Stroke Spasticity – Canadian Council On Continuing Education In Pharmacy (CCCEP)
CAN-eng
$0
free
Neurology
1 Credits
Course Description
Course Details
Expiry Date: 2018-01-13
Faculty
Accreditation
Learning Objective(s)
Upon completion of this program, participants will be able to:
- Describe the incidence, prevalence and risk of spasticity in post-stroke patients.
- Identify which patients should be treated for post-stroke spasticity, and why.
- Discuss the role of botulinum toxin type A in improving patient outcomes, including supporting real world evidence.
- Explore the role of pharmacists in helping post-stroke patients transition from the in-patient to out-patient / long term care setting.